Biotechnology
The Biotechnology industry has a total of 592 stocks, with a combined market cap of $1.18 trillion and total revenue of $110.17 billion.
Market Cap
1.18T
Revenue
110.17B
Profits
-39.86B
PE Ratio
n/a
Profit Margin
-36.19%
Dividend Yield
0.04%
592 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 111.05B | -0.59% | 986,799 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.69B | -0.27% | 706,496 | 14.34B |
| 3 | ARGX | argenx SE | 50.17B | -3.48% | 270,414 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.90B | -0.81% | 1,510,825 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 34.63B | -1.81% | 190,568 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.32B | 1.83% | 2,827,834 | - |
| 7 | INSM | Insmed Incorporated | 30.43B | -1.29% | 1,591,163 | 606.42M |
| 8 | RPRX | Royalty Pharma plc | 29.33B | 0.37% | 4,270,897 | 2.38B |
| 9 | BNTX | BioNTech SE | 28.22B | 6.09% | 2,753,464 | 3.37B |
| 10 | MRNA | Moderna, Inc. | 21.51B | -0.66% | 6,195,339 | 1.94B |
| 11 | ROIV | Roivant Sciences Ltd. | 20.96B | 0.72% | 2,946,101 | 13.31M |
| 12 | SMMT | Summit Therapeutics Inc. | 20.45B | 5.02% | 10,196,611 | - |
| 13 | INCY | Incyte Corporation | 19.15B | -0.72% | 1,478,414 | 5.14B |
| 14 | GMAB | Genmab A/S | 16.71B | -3.05% | 3,779,304 | 3.72B |
| 15 | ASND | Ascendis Pharma A/S | 14.85B | -2.07% | 558,221 | 845.52M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.77B | -0.65% | 1,466,882 | 502.08M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.35B | -0.12% | 1,818,668 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 12.25B | -1.74% | 990,797 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.11B | 0.11% | 209,211 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.66B | 5.23% | 3,497,944 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.50B | -0.47% | 1,502,055 | 3.22B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.95B | 2.60% | 2,208,003 | 1.09B |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 9.49B | -0.51% | 414,269 | 7.46M |
| 24 | AXSM | Axsome Therapeutics, Inc. | 9.36B | -3.03% | 717,316 | 638.50M |
| 25 | TECH | Bio-Techne Corporation | 9.34B | -1.50% | 1,992,252 | 1.22B |
| 26 | ABVX | ABIVAX Société Anonyme | 9.12B | -3.09% | 753,005 | 5.37M |
| 27 | PCVX | Vaxcyte, Inc. | 8.71B | -2.32% | 1,014,539 | - |
| 28 | NUVL | Nuvalent, Inc. | 8.42B | -1.03% | 787,024 | - |
| 29 | IBRX | ImmunityBio, Inc. | 8.37B | -1.22% | 13,169,735 | 113.29M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.10B | -1.67% | 1,542,619 | 1.40B |
| 31 | CYTK | Cytokinetics, Incorporated | 8.10B | -0.51% | 1,174,733 | 88.04M |
| 32 | KRYS | Krystal Biotech, Inc. | 8.03B | -1.39% | 160,920 | 389.13M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.19B | 1.31% | 502,293 | 39.21M |
| 34 | ERAS | Erasca, Inc. | 6.97B | 3.22% | 8,969,452 | - |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.76B | 0.40% | 494,871 | 46.02M |
| 36 | ACLX | Arcellx, Inc. | 6.75B | -0.02% | 723,768 | 22.29M |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.71B | -0.07% | 515,552 | - |
| 38 | BLTE | Belite Bio, Inc | 6.50B | -0.12% | 90,352 | - |
| 39 | SYRE | Spyre Therapeutics, Inc. | 6.15B | -2.89% | 1,135,729 | - |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.11B | -0.05% | 2,320,589 | 15.00M |
| 41 | TERN | Terns Pharmaceuticals, Inc. | 6.10B | 0.23% | 6,216,452 | - |
| 42 | CELC | Celcuity Inc. | 6.09B | 4.98% | 751,411 | - |
| 43 | CGON | CG Oncology, Inc. | 6.07B | 2.05% | 805,997 | 4.04M |
| 44 | COGT | Cogent Biosciences, Inc. | 5.92B | -0.73% | 1,902,918 | - |
| 45 | CAI | Caris Life Sciences, Inc. | 5.89B | -1.93% | 2,056,567 | 812.03M |
| 46 | PTCT | PTC Therapeutics, Inc. | 5.85B | -2.34% | 724,194 | 1.73B |
| 47 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.80B | -3.19% | 507,151 | 189.76M |
| 48 | IMVT | Immunovant, Inc. | 5.76B | -0.88% | 1,154,647 | - |
| 49 | MIRM | Mirum Pharmaceuticals, Inc. | 5.63B | -2.49% | 635,322 | 521.31M |
| 50 | SRRK | Scholar Rock Holding Corporation | 5.53B | 0.63% | 1,342,157 | - |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 5.38B | -1.21% | 666,643 | 7.50M |
| 52 | TGTX | TG Therapeutics, Inc. | 5.36B | -1.84% | 2,078,802 | 616.29M |
| 53 | CRSP | CRISPR Therapeutics AG | 5.33B | -3.73% | 2,248,735 | 3.51M |
| 54 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | - | 4,067,937 | 1.00B |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.91B | -1.93% | 441,039 | 2.04M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.80B | -2.68% | 961,424 | 761.41M |
| 57 | LEGN | Legend Biotech Corporation | 4.66B | 0.60% | 3,871,417 | 1.03B |
| 58 | FOLD | Amicus Therapeutics, Inc. | 4.54B | - | 2,587,417 | 634.21M |
| 59 | LGND | Ligand Pharmaceuticals Incorporated | 4.52B | -2.20% | 127,704 | 268.09M |
| 60 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.07B | -3.35% | 893,067 | 7.70M |
| 61 | TNGX | Tango Therapeutics, Inc. | 3.96B | 5.23% | 3,033,561 | 62.38M |
| 62 | VKTX | Viking Therapeutics, Inc. | 3.92B | -4.87% | 3,307,522 | - |
| 63 | NAMS | NewAmsterdam Pharma Company N.V. | 3.73B | -3.96% | 942,422 | 22.50M |
| 64 | ACAD | ACADIA Pharmaceuticals Inc. | 3.72B | -1.31% | 991,559 | 1.07B |
| 65 | TVTX | Travere Therapeutics, Inc. | 3.58B | -3.75% | 1,917,418 | 490.73M |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.52B | -4.66% | 170,178 | 803.79M |
| 67 | EWTX | Edgewise Therapeutics, Inc. | 3.48B | -4.47% | 711,142 | - |
| 68 | ORKA | Oruka Therapeutics, Inc. | 3.42B | 0.19% | 733,516 | - |
| 69 | GPCR | Structure Therapeutics Inc. | 3.32B | -2.88% | 1,025,499 | - |
| 70 | DNLI | Denali Therapeutics Inc. | 3.19B | -2.00% | 1,025,702 | - |
| 71 | ALMS | Alumis Inc. | 3.18B | 1.09% | 1,695,635 | 24.05M |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.17B | -4.05% | 2,358,693 | - |
| 73 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.13B | -1.65% | 835,397 | 588.99M |
| 74 | KLRA | Kailera Therapeutics, Inc. | 3.12B | 2.48% | 843,037 | - |
| 75 | RCUS | Arcus Biosciences, Inc. | 3.07B | 7.83% | 3,647,920 | 247.00M |
| 76 | BEAM | Beam Therapeutics Inc. | 3.05B | -1.60% | 1,747,088 | 139.74M |
| 77 | RLAY | Relay Therapeutics, Inc. | 3.00B | 2.44% | 2,526,902 | 15.36M |
| 78 | ARQT | Arcutis Biotherapeutics, Inc. | 2.90B | -4.37% | 989,695 | 376.07M |
| 79 | VERA | Vera Therapeutics, Inc. | 2.87B | -3.73% | 686,547 | - |
| 80 | KOD | Kodiak Sciences Inc. | 2.85B | -0.65% | 560,230 | - |
| 81 | NKTR | Nektar Therapeutics | 2.82B | -2.18% | 1,602,482 | 55.23M |
| 82 | IDYA | IDEAYA Biosciences, Inc. | 2.80B | -5.27% | 1,391,864 | 218.71M |
| 83 | ZLAB | Zai Lab Limited | 2.75B | -3.21% | 1,424,253 | 460.16M |
| 84 | TARS | Tarsus Pharmaceuticals, Inc. | 2.75B | -2.21% | 717,065 | 451.36M |
| 85 | ELVN | Enliven Therapeutics, Inc. | 2.74B | -1.12% | 782,034 | - |
| 86 | MANE | Veradermics, Incorporated | 2.74B | -0.84% | 161,814 | - |
| 87 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.04% | 1,804,265 | 190.41M |
| 88 | IMNM | Immunome, Inc. | 2.70B | -1.65% | 408,734 | 6.94M |
| 89 | CLDX | Celldex Therapeutics, Inc. | 2.69B | -0.38% | 797,805 | 1.55M |
| 90 | IRON | Disc Medicine, Inc. | 2.64B | -3.26% | 275,529 | - |
| 91 | ADMA | ADMA Biologics, Inc. | 2.50B | -0.92% | 5,310,267 | 510.17M |
| 92 | AAPG | Ascentage Pharma Group International | 2.42B | -2.69% | 4,723 | 82.08M |
| 93 | DFTX | Definium Therapeutics, Inc. | 2.38B | 2.85% | 2,634,049 | - |
| 94 | MLYS | Mineralys Therapeutics, Inc. | 2.37B | -4.29% | 1,062,554 | - |
| 95 | RARE | Ultragenyx Pharmaceutical Inc. | 2.36B | -3.83% | 1,387,142 | 673.00M |
| 96 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.05% | 2,117,966 | 158.18M |
| 97 | ADPT | Adaptive Biotechnologies Corporation | 2.19B | -2.54% | 1,531,103 | 276.98M |
| 98 | SRPT | Sarepta Therapeutics, Inc. | 2.17B | -3.45% | 2,757,013 | 2.20B |
| 99 | MESO | Mesoblast Limited | 2.14B | -2.59% | 164,580 | 65.38M |
| 100 | STOK | Stoke Therapeutics, Inc. | 2.11B | -2.33% | 428,948 | 184.42M |
| 101 | AUPH | Aurinia Pharmaceuticals Inc. | 2.10B | -0.88% | 837,650 | 283.06M |
| 102 | ZYME | Zymeworks Inc. | 2.08B | 1.51% | 490,705 | 105.97M |
| 103 | SNDX | Syndax Pharmaceuticals, Inc. | 2.06B | -1.89% | 1,192,859 | 172.35M |
| 104 | TRVI | Trevi Therapeutics, Inc. | 2.05B | -5.06% | 2,309,462 | - |
| 105 | CAPR | Capricor Therapeutics, Inc. | 2.04B | 3.30% | 803,285 | 11.13M |
| 106 | OCUL | Ocular Therapeutix, Inc. | 2.03B | -2.10% | 3,515,896 | 51.95M |
| 107 | TYRA | Tyra Biosciences, Inc. | 1.98B | 6.75% | 1,266,869 | - |
| 108 | GLPG | Galapagos NV | 1.91B | -1.20% | 180,209 | 1.31B |
| 109 | PHVS | Pharvaris N.V. | 1.91B | 0.62% | 83,185 | - |
| 110 | SION | Sionna Therapeutics, Inc. | 1.88B | -1.99% | 366,738 | - |
| 111 | RXRX | Recursion Pharmaceuticals, Inc. | 1.88B | -3.52% | 11,885,366 | 74.68M |
| 112 | PVLA | Palvella Therapeutics, Inc. | 1.87B | 1.02% | 233,148 | - |
| 113 | HRMY | Harmony Biosciences Holdings, Inc. | 1.86B | 8.84% | 3,943,226 | 868.45M |
| 114 | NTLA | Intellia Therapeutics, Inc. | 1.81B | 0.66% | 4,309,902 | 67.67M |
| 115 | TSHA | Taysha Gene Therapies, Inc. | 1.79B | -3.72% | 2,050,040 | 9.77M |
| 116 | NUVB | Nuvation Bio Inc. | 1.78B | -0.20% | 2,889,609 | 62.90M |
| 117 | ATAI | AtaiBeckley Inc. | 1.78B | -0.61% | 14,758,097 | 4.09M |
| 118 | RAPP | Rapport Therapeutics, Inc. | 1.77B | -0.51% | 428,226 | - |
| 119 | INVA | Innoviva, Inc. | 1.75B | -1.30% | 536,618 | 411.33M |
| 120 | VIR | Vir Biotechnology, Inc. | 1.75B | -2.34% | 1,409,474 | 68.56M |
| 121 | VCEL | Vericel Corporation | 1.71B | -5.98% | 659,763 | 276.26M |
| 122 | NRIX | Nurix Therapeutics, Inc. | 1.70B | -3.52% | 831,151 | 71.78M |
| 123 | GLUE | Monte Rosa Therapeutics, Inc. | 1.67B | 5.45% | 876,817 | 123.67M |
| 124 | OCS | Oculis Holding AG | 1.62B | -4.30% | 1,083,722 | 1.51M |
| 125 | DMRA | Damora Therapeutics, Inc. | 1.62B | 1.48% | 189,547 | - |
| 126 | GENB | Generate Biomedicines, Inc. | 1.61B | 4.54% | 620,329 | 31.89M |
| 127 | MBX | MBX Biosciences, Inc. | 1.58B | -1.60% | 436,267 | - |
| 128 | AGIO | Agios Pharmaceuticals, Inc. | 1.54B | -2.88% | 1,616,613 | 54.03M |
| 129 | BHVN | Biohaven Ltd. | 1.53B | -5.82% | 2,020,275 | - |
| 130 | IOVA | Iovance Biotherapeutics, Inc. | 1.52B | -2.12% | 10,956,528 | 263.50M |
| 131 | BCAX | Bicara Therapeutics Inc. | 1.51B | -1.53% | 613,697 | - |
| 132 | NBTX | Nanobiotix S.A. | 1.50B | -3.54% | 88,941 | 38.27M |
| 133 | IMTX | Immatics N.V. | 1.50B | -0.62% | 282,235 | 56.67M |
| 134 | IMCR | Immunocore Holdings plc | 1.50B | -6.17% | 434,222 | 400.02M |
| 135 | ANAB | AnaptysBio, Inc. | 1.49B | 1.71% | 643,270 | 234.60M |
| 136 | ARDX | Ardelyx, Inc. | 1.46B | -5.40% | 3,963,310 | 407.32M |
| 137 | VRDN | Viridian Therapeutics, Inc. | 1.46B | -2.72% | 2,076,793 | 70.85M |
| 138 | OLMA | Olema Pharmaceuticals, Inc. | 1.45B | 0.30% | 751,195 | - |
| 139 | CRVS | Corvus Pharmaceuticals, Inc. | 1.44B | 10.30% | 1,486,677 | - |
| 140 | WVE | Wave Life Sciences Ltd. | 1.41B | -3.17% | 4,337,101 | 42.73M |
| 141 | PGEN | Precigen, Inc. | 1.41B | -3.16% | 1,653,129 | 9.68M |
| 142 | NVAX | Novavax, Inc. | 1.38B | -2.08% | 3,959,711 | 1.12B |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.37B | -1.31% | 630,334 | - |
| 144 | SVRA | Savara Inc. | 1.34B | -5.88% | 1,226,139 | - |
| 145 | GHRS | GH Research PLC | 1.28B | -3.95% | 454,021 | - |
| 146 | MAZE | Maze Therapeutics, Inc. | 1.28B | -4.28% | 716,552 | 2.50M |
| 147 | MLTX | MoonLake Immunotherapeutics | 1.24B | -3.75% | 729,751 | - |
| 148 | INBX | Inhibrx Biosciences, Inc. | 1.23B | 2.06% | 704,769 | 1.30M |
| 149 | URGN | UroGen Pharma Ltd. | 1.22B | 0.44% | 1,115,437 | 109.79M |
| 150 | MPLT | MapLight Therapeutics, Inc. | 1.22B | -2.54% | 425,516 | - |
| 151 | ZBIO | Zenas BioPharma, Inc. | 1.22B | -2.20% | 426,620 | 10.00M |
| 152 | ABCL | AbCellera Biologics Inc. | 1.21B | 2.05% | 3,867,207 | 75.13M |
| 153 | PHAR | Pharming Group N.V. | 1.21B | -2.50% | 4,396 | 376.13M |
| 154 | DBVT | DBV Technologies S.A. | 1.19B | -4.90% | 386,427 | 5.64M |
| 155 | EYPT | EyePoint, Inc. | 1.18B | -6.37% | 1,421,359 | 31.37M |
| 156 | SEPN | Septerna, Inc. | 1.16B | -3.95% | 363,362 | 45.95M |
| 157 | JBIO | Jade Biosciences, Inc. | 1.13B | -2.09% | 793,493 | - |
| 158 | AKTS | Aktis Oncology, Inc. | 1.13B | -1.58% | 294,876 | 6.50M |
| 159 | IVA | Inventiva S.A. | 1.12B | -3.40% | 164,862 | 7.94M |
| 160 | QURE | uniQure N.V. | 1.10B | -3.27% | 1,128,304 | 16.10M |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 1.07B | -2.39% | 1,279,166 | - |
| 162 | CTMX | CytomX Therapeutics, Inc. | 1.03B | -2.66% | 3,915,473 | 76.20M |
| 163 | PHAT | Phathom Pharmaceuticals, Inc. | 1.02B | -4.38% | 1,423,157 | 175.11M |
| 164 | XERS | Xeris Biopharma Holdings, Inc. | 1.02B | -5.76% | 1,701,787 | 291.85M |
| 165 | SANA | Sana Biotechnology, Inc. | 1.02B | -3.14% | 4,052,215 | - |
| 166 | EVMN | Evommune, Inc. | 1.01B | 0.36% | 157,869 | 13.00M |
| 167 | KALV | KalVista Pharmaceuticals, Inc. | 995.25M | -6.90% | 1,298,985 | 73.62M |
| 168 | ANNX | Annexon, Inc. | 994.94M | -3.58% | 1,695,133 | - |
| 169 | FTRE | Fortrea Holdings Inc. | 964.92M | -1.15% | 1,084,834 | 2.72B |
| 170 | GERN | Geron Corporation | 961.35M | -3.85% | 13,609,397 | 183.88M |
| 171 | OMER | Omeros Corporation | 954.67M | -1.56% | 828,956 | - |
| 172 | MRVI | Maravai LifeSciences Holdings, Inc. | 946.01M | 1.94% | 2,513,653 | 185.74M |
| 173 | CMPX | Compass Therapeutics, Inc. | 943.66M | -3.23% | 2,735,308 | 850.00K |
| 174 | MGTX | MeiraGTx Holdings plc | 941.31M | -3.42% | 1,262,073 | 81.39M |
| 175 | JANX | Janux Therapeutics, Inc. | 940.46M | -2.58% | 1,965,809 | 10.00M |
| 176 | XNCR | Xencor, Inc. | 924.80M | -1.48% | 395,678 | 125.58M |
| 177 | LBRX | LB Pharmaceuticals Inc | 911.29M | 0.35% | 333,487 | - |
| 178 | SLS | SELLAS Life Sciences Group, Inc. | 903.30M | 0.80% | 4,397,022 | - |
| 179 | ANRO | Alto Neuroscience, Inc. | 897.00M | -6.37% | 318,541 | - |
| 180 | DRUG | Bright Minds Biosciences Inc. | 882.87M | -3.71% | 235,159 | - |
| 181 | ABUS | Arbutus Biopharma Corporation | 872.44M | -3.70% | 914,675 | 14.08M |
| 182 | CGEM | Cullinan Therapeutics, Inc. | 860.68M | -2.07% | 673,807 | - |
| 183 | TBPH | Theravance Biopharma, Inc. | 855.81M | -0.60% | 478,892 | 107.46M |
| 184 | KURA | Kura Oncology, Inc. | 840.58M | -3.17% | 1,533,813 | 67.48M |
| 185 | MNKD | MannKind Corporation | 833.75M | -7.53% | 4,528,435 | 348.97M |
| 186 | SGP | SpyGlass Pharma, Inc. | 822.13M | 0.31% | 30,339 | - |
| 187 | VOR | Vor Biopharma Inc. | 822.00M | -3.44% | 1,146,696 | - |
| 188 | DSGN | Design Therapeutics, Inc. | 819.62M | 0.99% | 453,772 | - |
| 189 | CBIO | Crescent Biopharma, Inc. | 816.07M | 13.28% | 544,040 | 10.84M |
| 190 | FBRX | Forte Biosciences, Inc. | 803.86M | -4.62% | 202,068 | - |
| 191 | SLDB | Solid Biosciences Inc. | 802.90M | -3.89% | 991,833 | - |
| 192 | ALLO | Allogene Therapeutics, Inc. | 798.03M | -4.13% | 8,823,016 | 22.00K |
| 193 | SPRY | ARS Pharmaceuticals, Inc. | 778.49M | -4.16% | 1,481,718 | 84.28M |
| 194 | LXRX | Lexicon Pharmaceuticals, Inc. | 775.34M | -0.54% | 1,402,013 | 49.80M |
| 195 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 757.11M | 2.16% | 881,452 | - |
| 196 | RLMD | Relmada Therapeutics, Inc. | 748.90M | -3.12% | 1,978,572 | - |
| 197 | GYRE | Gyre Therapeutics, Inc. | 718.64M | -0.88% | 68,833 | 116.59M |
| 198 | DRTS | Alpha Tau Medical Ltd. | 695.28M | -2.59% | 158,568 | - |
| 199 | TENX | Tenax Therapeutics, Inc. | 688.11M | -2.98% | 274,054 | - |
| 200 | ARVN | Arvinas, Inc. | 679.27M | -1.76% | 679,284 | 262.60M |
| 201 | PRME | Prime Medicine, Inc. | 674.67M | -2.06% | 2,129,099 | 4.63M |
| 202 | ANL | Adlai Nortye Ltd. | 638.40M | -3.86% | 385,434 | 5.00M |
| 203 | EIKN | Eikon Therapeutics, Inc. | 635.59M | 1.65% | 127,792 | - |
| 204 | PROK | ProKidney Corp. | 631.00M | -0.48% | 529,118 | 893.00K |
| 205 | ZVRA | Zevra Therapeutics, Inc. | 610.01M | -3.62% | 764,392 | 106.47M |
| 206 | OCGN | Ocugen, Inc. | 598.08M | -4.32% | 4,009,583 | 4.41M |
| 207 | ABSI | Absci Corporation | 596.78M | -1.27% | 6,080,148 | 2.80M |
| 208 | RIGL | Rigel Pharmaceuticals, Inc. | 596.50M | -0.62% | 248,438 | 294.28M |
| 209 | TRAX | First Tracks Biotherapeutics, Inc. | 590.73M | -8.60% | 1,031,451 | - |
| 210 | KYTX | Kyverna Therapeutics, Inc. | 587.75M | -13.69% | 1,765,349 | - |
| 211 | STTK | Shattuck Labs, Inc. | 586.51M | -1.52% | 386,325 | 1.00M |
| 212 | CRMD | CorMedix Inc. | 583.39M | -2.64% | 798,471 | 311.71M |
| 213 | ACRS | Aclaris Therapeutics, Inc. | 579.61M | -1.88% | 1,711,348 | 7.83M |
| 214 | PRTA | Prothena Corporation plc | 574.40M | -1.11% | 451,035 | 9.68M |
| 215 | ENGN | enGene Therapeutics Inc. | 570.08M | -0.23% | 173,553 | - |
| 216 | STRO | Sutro Biopharma, Inc. | 569.08M | -0.67% | 192,587 | 102.48M |
| 217 | LYEL | Lyell Immunopharma, Inc. | 557.90M | -3.92% | 76,433 | 36.00K |
| 218 | ARMP | Armata Pharmaceuticals, Inc. | 542.17M | 18.40% | 141,666 | 4.90M |
| 219 | AGMB | AgomAb Therapeutics NV | 533.67M | 1.48% | 97,041 | - |
| 220 | VSTM | Verastem, Inc. | 531.45M | -7.21% | 1,578,254 | 30.91M |
| 221 | VALN | Valneva SE | 529.55M | -1.82% | 72,607 | 205.07M |
| 222 | ADCT | ADC Therapeutics SA | 522.75M | -3.29% | 1,381,902 | 81.36M |
| 223 | TECX | Tectonic Therapeutic, Inc. | 518.99M | -3.89% | 403,261 | - |
| 224 | IMMX | Immix Biopharma, Inc. | 513.16M | -4.06% | 1,554,432 | - |
| 225 | CADL | Candel Therapeutics, Inc. | 512.73M | -3.05% | 3,513,016 | - |
| 226 | UPB | Upstream Bio, Inc. | 503.93M | -7.31% | 526,920 | 2.85M |
| 227 | ZURA | Zura Bio Limited | 501.92M | -1.49% | 591,078 | - |
| 228 | FULC | Fulcrum Therapeutics, Inc. | 501.50M | -5.16% | 838,961 | 80.00M |
| 229 | FDMT | 4D Molecular Therapeutics, Inc. | 498.26M | -3.08% | 843,247 | 85.21M |
| 230 | CTNM | Contineum Therapeutics, Inc. | 490.97M | -2.38% | 92,263 | - |
| 231 | DNA | Ginkgo Bioworks Holdings, Inc. | 477.88M | 2.88% | 1,223,842 | 170.16M |
| 232 | AURA | Aura Biosciences, Inc. | 477.28M | 5.53% | 383,594 | - |
| 233 | MDXG | MiMedx Group, Inc. | 475.41M | -1.54% | 1,975,024 | 418.63M |
| 234 | VTVT | vTv Therapeutics Inc. | 475.28M | 1.46% | 69,098 | 17.00K |
| 235 | LRMR | Larimar Therapeutics, Inc. | 474.75M | -4.99% | 963,071 | - |
| 236 | XOMA | XOMA Royalty Corporation | 471.62M | -1.05% | 101,518 | 52.15M |
| 237 | TRDA | Entrada Therapeutics, Inc. | 470.52M | -3.61% | 99,231 | 25.42M |
| 238 | RGNX | REGENXBIO Inc. | 470.23M | -3.80% | 638,686 | 170.44M |
| 239 | PALI | Palisade Bio, Inc. | 468.78M | 12.00% | 10,791,773 | - |
| 240 | LXEO | Lexeo Therapeutics, Inc. | 466.01M | -3.68% | 764,099 | - |
| 241 | BNTC | Benitec Biopharma Inc. | 451.48M | -5.79% | 87,385 | - |
| 242 | IVVD | Invivyd, Inc. | 449.66M | -5.36% | 1,146,901 | 53.43M |
| 243 | CLYM | Climb Bio, Inc. | 447.59M | 4.46% | 754,549 | - |
| 244 | ALT | Altimmune, Inc. | 443.66M | -4.21% | 3,250,804 | 41.00K |
| 245 | AVIR | Atea Pharmaceuticals, Inc. | 439.79M | -3.33% | 397,083 | - |
| 246 | EPRX | Eupraxia Pharmaceuticals Inc. | 433.91M | -2.50% | 192,202 | - |
| 247 | PRTC | PureTech Health plc | 430.07M | -1.69% | 1,324 | 6.39M |
| 248 | ASMB | Assembly Biosciences, Inc. | 428.45M | -3.98% | 183,010 | 72.30M |
| 249 | NMRA | Neumora Therapeutics, Inc. | 422.33M | 5.94% | 1,887,375 | - |
| 250 | IPSC | Century Therapeutics, Inc. | 413.36M | -1.71% | 778,803 | 109.16M |
| 251 | NGNE | Neurogene Inc. | 412.72M | -4.47% | 137,094 | 925.00K |
| 252 | AUTL | Autolus Therapeutics plc | 412.52M | -1.90% | 974,584 | 75.39M |
| 253 | LCTX | Lineage Cell Therapeutics, Inc. | 408.50M | -0.61% | 818,709 | 14.56M |
| 254 | VNDA | Vanda Pharmaceuticals Inc. | 400.75M | -3.00% | 1,048,012 | 216.11M |
| 255 | RCKT | Rocket Pharmaceuticals, Inc. | 399.39M | -5.18% | 1,586,466 | - |
| 256 | ENTA | Enanta Pharmaceuticals, Inc. | 383.78M | -4.03% | 114,829 | 66.98M |
| 257 | AVTX | Avalo Therapeutics, Inc. | 381.75M | -2.52% | 681,348 | 59.00K |
| 258 | PRLD | Prelude Therapeutics Incorporated | 381.31M | 2.44% | 389,833 | 12.14M |
| 259 | NAGE | Niagen Bioscience, Inc. | 380.37M | -2.67% | 573,387 | 129.42M |
| 260 | IRD | Opus Genetics, Inc. | 379.94M | -3.61% | 498,947 | 14.20M |
| 261 | XFOR | X4 Pharmaceuticals, Inc. | 379.14M | -0.48% | 232,235 | 35.11M |
| 262 | OVID | Ovid Therapeutics Inc. | 375.84M | -1.38% | 2,850,039 | 7.25M |
| 263 | PBYI | Puma Biotechnology, Inc. | 369.36M | -1.49% | 169,229 | 228.37M |
| 264 | SLN | Silence Therapeutics plc | 365.12M | -2.52% | 490,237 | 559.00K |
| 265 | YDES | YD Bio Limited | 362.99M | -2.79% | 31,749 | 510.36K |
| 266 | IMRX | Immuneering Corporation | 358.82M | 0.36% | 735,696 | - |
| 267 | SRZN | Surrozen, Inc. | 357.24M | -3.57% | 116,162 | 3.48M |
| 268 | MNPR | Monopar Therapeutics Inc. | 352.74M | -3.64% | 185,408 | - |
| 269 | NAUT | Nautilus Biotechnology, Inc. | 351.85M | -6.08% | 244,409 | - |
| 270 | CABA | Cabaletta Bio, Inc. | 348.44M | -5.30% | 2,529,318 | - |
| 271 | DMAC | DiaMedica Therapeutics Inc. | 345.93M | -2.13% | 114,693 | - |
| 272 | BCYC | Bicycle Therapeutics plc | 343.66M | -6.81% | 581,501 | 72.59M |
| 273 | RZLT | Rezolute, Inc. | 340.70M | -2.67% | 1,033,573 | - |
| 274 | AVXL | Anavex Life Sciences Corp. | 324.35M | -4.11% | 767,998 | - |
| 275 | EDIT | Editas Medicine, Inc. | 322.98M | -7.56% | 1,597,076 | 40.52M |
| 276 | GLSI | Greenwich LifeSciences, Inc. | 317.41M | -6.57% | 185,191 | - |
| 277 | NGEN | NervGen Pharma Corp. | 314.01M | -3.00% | 143,879 | - |
| 278 | ARTV | Artiva Biotherapeutics, Inc. | 309.95M | -6.35% | 509,604 | 251.00K |
| 279 | LENZ | LENZ Therapeutics, Inc. | 309.47M | -2.57% | 488,969 | 19.09M |
| 280 | FHTX | Foghorn Therapeutics Inc. | 309.35M | -4.36% | 96,244 | 30.91M |
| 281 | ABEO | Abeona Therapeutics Inc. | 306.92M | -1.82% | 726,921 | 5.82M |
| 282 | NERV | Minerva Neurosciences, Inc. | 305.14M | 1.02% | 232,048 | - |
| 283 | CCCC | C4 Therapeutics, Inc. | 304.44M | 4.35% | 3,325,458 | 35.95M |
| 284 | ELDN | Eledon Pharmaceuticals, Inc. | 300.83M | -4.35% | 2,143,040 | - |
| 285 | NBP | NovaBridge Biosciences | 297.22M | -3.02% | 456,195 | - |
| 286 | CLLS | Cellectis S.A. | 292.82M | -2.44% | 44,687 | 79.59M |
| 287 | TARA | Protara Therapeutics, Inc. | 287.73M | 0.38% | 1,091,337 | - |
| 288 | ACIU | AC Immune SA | 284.71M | -3.69% | 93,663 | 4.51M |
| 289 | IKT | Inhibikase Therapeutics, Inc. | 284.61M | -7.73% | 2,591,937 | 1.00 |
| 290 | ZNTL | Zentalis Pharmaceuticals, Inc. | 283.01M | -0.99% | 1,307,584 | 26.87M |
| 291 | CHRS | Coherus Oncology, Inc. | 280.68M | -8.54% | 1,938,693 | 42.17M |
| 292 | ALEC | Alector, Inc. | 271.49M | -9.06% | 298,677 | 21.05M |
| 293 | CGEN | Compugen Ltd. | 268.53M | -1.39% | 278,344 | 72.76M |
| 294 | SABS | SAB Biotherapeutics, Inc. | 267.75M | -1.30% | 413,175 | 114.70K |
| 295 | ADAG | Adagene Inc. | 251.08M | -2.31% | 295,322 | 7.67M |
| 296 | ARCT | Arcturus Therapeutics Holdings Inc. | 250.69M | -0.90% | 302,687 | 82.03M |
| 297 | PLYX | Polaryx Therapeutics, Inc. | 249.50M | -7.54% | 810,453 | - |
| 298 | OBIO | Orchestra BioMed Holdings, Inc. | 246.96M | -2.99% | 118,458 | 33.48M |
| 299 | HELP | Cybin Inc. | 246.68M | -12.12% | 3,542,711 | - |
| 300 | VYGR | Voyager Therapeutics, Inc. | 245.55M | -2.60% | 375,796 | 40.37M |
| 301 | SLGL | Sol-Gel Technologies Ltd. | 241.50M | 5.54% | 16,519 | 19.39M |
| 302 | CAMP | Camp4 Therapeutics Corporation | 237.27M | 1.33% | 22,547 | 3.50M |
| 303 | NKTX | Nkarta, Inc. | 236.68M | -4.87% | 1,501,452 | - |
| 304 | MIST | Milestone Pharmaceuticals Inc. | 235.49M | -5.88% | 1,795,953 | 1.55M |
| 305 | NVCT | Nuvectis Pharma, Inc. | 227.30M | 3.00% | 66,505 | - |
| 306 | FENC | Fennec Pharmaceuticals Inc. | 225.98M | -2.60% | 71,725 | 44.64M |
| 307 | ACHV | Achieve Life Sciences, Inc. | 224.14M | -0.94% | 1,527,485 | - |
| 308 | ELTX | Elicio Therapeutics, Inc. | 224.06M | -0.16% | 85,032 | - |
| 309 | ALXO | ALX Oncology Holdings Inc. | 223.73M | -2.86% | 900,558 | - |
| 310 | KROS | Keros Therapeutics, Inc. | 223.01M | -3.00% | 293,096 | 244.06M |
| 311 | MGNX | MacroGenics, Inc. | 220.55M | -0.29% | 721,396 | 149.50M |
| 312 | CDXS | Codexis, Inc. | 219.00M | -8.02% | 1,390,940 | 70.39M |
| 313 | CNTX | Context Therapeutics Inc. | 217.75M | 4.87% | 1,193,598 | - |
| 314 | CRBU | Caribou Biosciences, Inc. | 217.43M | -1.75% | 1,941,284 | 11.16M |
| 315 | OABI | OmniAb, Inc. | 214.28M | -4.52% | 638,903 | 18.67M |
| 316 | MDWD | MediWound Ltd. | 213.35M | -4.32% | 46,527 | 16.96M |
| 317 | ENLV | Enlivex Ltd. | 208.54M | 0.30% | 474,727 | - |
| 318 | KPTI | Karyopharm Therapeutics Inc. | 206.72M | 2.57% | 954,166 | 146.07M |
| 319 | WHWK | Whitehawk Therapeutics, Inc. | 198.23M | -0.71% | 90,285 | 7.15M |
| 320 | ABOS | Acumen Pharmaceuticals, Inc. | 197.14M | -3.87% | 277,827 | - |
| 321 | KRRO | Korro Bio, Inc. | 194.56M | -5.53% | 67,124 | 6.39M |
| 322 | SGMT | Sagimet Biosciences Inc. | 192.58M | -8.23% | 432,156 | - |
| 323 | HRTX | Heron Therapeutics, Inc. | 192.31M | -2.86% | 2,406,205 | 154.90M |
| 324 | DTIL | Precision BioSciences, Inc. | 191.98M | -1.85% | 130,999 | 34.26M |
| 325 | TNXP | Tonix Pharmaceuticals Holding Corp. | 191.91M | -5.79% | 300,204 | 13.11M |
| 326 | CNTN | Canton Strategic Holdings, Inc. | 188.10M | -5.41% | 354,017 | - |
| 327 | RNAC | Cartesian Therapeutics, Inc. | 184.37M | 0.22% | 127,189 | 2.80M |
| 328 | PRQR | ProQR Therapeutics N.V. | 182.80M | -5.71% | 557,395 | 19.19M |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 182.60M | -3.06% | 185,735 | - |
| 330 | UNCY | Unicycive Therapeutics, Inc. | 181.96M | -2.96% | 379,893 | - |
| 331 | BDTX | Black Diamond Therapeutics, Inc. | 180.46M | 3.28% | 1,089,417 | 70.00M |
| 332 | PLX | Protalix BioTherapeutics, Inc. | 178.87M | -2.20% | 487,476 | 52.74M |
| 333 | HURA | TuHURA Biosciences, Inc. | 176.75M | -1.77% | 1,123,979 | - |
| 334 | KALA | KALA BIO, Inc. | 172.05M | -7.45% | 6,794,236 | - |
| 335 | MENS | Jyong Biotech Ltd. | 166.87M | -6.06% | 82,943 | - |
| 336 | MOLN | Molecular Partners AG | 165.88M | -1.36% | 912 | 856.30K |
| 337 | SPRO | Spero Therapeutics, Inc. | 162.10M | -1.41% | 266,208 | 66.80M |
| 338 | TLSA | Tiziana Life Sciences Ltd | 156.98M | 1.65% | 99,638 | - |
| 339 | FATE | Fate Therapeutics, Inc. | 156.96M | -2.88% | 1,215,286 | 6.65M |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 156.12M | 0.78% | 138,038 | 2.00M |
| 341 | REPL | Replimune Group, Inc. | 153.59M | -10.14% | 5,695,183 | - |
| 342 | TNYA | Tenaya Therapeutics, Inc. | 150.38M | -6.53% | 4,592,546 | - |
| 343 | AGEN | Agenus Inc. | 150.14M | -11.54% | 1,357,264 | 114.20M |
| 344 | GALT | Galectin Therapeutics Inc. | 150.09M | -0.44% | 312,227 | - |
| 345 | ACOG | Alpha Cognition Inc. | 149.81M | -0.15% | 43,002 | 10.22M |
| 346 | HUMA | Humacyte, Inc. | 146.31M | -4.15% | 4,159,019 | 2.04M |
| 347 | CNTB | Connect Biopharma Holdings Limited | 145.82M | -3.73% | 455,669 | 64.00K |
| 348 | KLRS | Kalaris Therapeutics, Inc. | 143.99M | -5.00% | 46,948 | - |
| 349 | IPHA | Innate Pharma S.A. | 138.74M | -4.40% | 7,893 | 10.57M |
| 350 | BMEA | Biomea Fusion, Inc. | 138.09M | -6.83% | 1,515,813 | - |
| 351 | ANTX | AN2 Therapeutics, Inc. | 136.75M | 4.97% | 133,838 | - |
| 352 | EQ | Equillium, Inc. | 135.94M | 6.97% | 360,952 | 4.39M |
| 353 | ONCY | Oncolytics Biotech Inc. | 130.06M | 0.90% | 693,964 | - |
| 354 | NTHI | NeOnc Technologies Holdings, Inc. | 128.05M | -0.48% | 27,459 | 39.99K |
| 355 | IFRX | InflaRx N.V. | 125.07M | 4.22% | 1,315,790 | 34.44K |
| 356 | IMUX | Immunic, Inc. | 117.54M | -5.66% | 2,395,867 | - |
| 357 | AARD | Aardvark Therapeutics, Inc. | 117.15M | -4.96% | 168,093 | - |
| 358 | KZIA | Kazia Therapeutics Limited | 117.01M | -2.38% | 228,474 | 1.27M |
| 359 | VANI | Vivani Medical, Inc. | 116.81M | -8.61% | 491,645 | - |
| 360 | CBUS | Cibus, Inc. | 114.26M | -3.85% | 452,678 | 3.64M |
| 361 | GNLX | Genelux Corporation | 113.59M | -3.40% | 174,186 | 8.00K |
| 362 | CRDF | Cardiff Oncology, Inc. | 112.80M | -7.30% | 815,188 | 593.00K |
| 363 | SEER | Seer, Inc. | 112.56M | 0.25% | 301,453 | 16.58M |
| 364 | PEPG | PepGen Inc. | 111.28M | -6.94% | 557,612 | - |
| 365 | VRCA | Verrica Pharmaceuticals Inc. | 108.57M | -0.94% | 75,224 | 35.58M |
| 366 | PYXS | Pyxis Oncology, Inc. | 107.44M | 0.59% | 207,949 | 13.86M |
| 367 | SGMO | Sangamo Therapeutics, Inc. | 106.68M | -4.66% | 5,379,610 | 39.55M |
| 368 | COYA | Coya Therapeutics, Inc. | 106.50M | -9.02% | 236,208 | 7.95M |
| 369 | CGTX | Cognition Therapeutics, Inc. | 104.54M | 4.46% | 3,572,896 | - |
| 370 | ALDX | Aldeyra Therapeutics, Inc. | 101.11M | -5.62% | 1,583,120 | - |
| 371 | TTRX | Turn Therapeutics Inc. | 99.79M | -0.89% | 25,726 | - |
| 372 | NRXP | NRx Pharmaceuticals, Inc. | 97.45M | -7.81% | 2,537,345 | 1.23M |
| 373 | ANIX | Anixa Biosciences, Inc. | 96.56M | -4.00% | 120,136 | - |
| 374 | PMN | ProMIS Neurosciences, Inc. | 96.22M | -6.29% | 54,106 | - |
| 375 | RANI | Rani Therapeutics Holdings, Inc. | 94.52M | -2.66% | 900,262 | 1.63M |
| 376 | QTTB | Q32 Bio Inc. | 93.92M | -3.46% | 528,140 | 53.74M |
| 377 | COEP | Coeptis Therapeutics Holdings, Inc. | 92.91M | -3.93% | 107,634 | 1.36M |
| 378 | INO | Inovio Pharmaceuticals, Inc. | 92.59M | -4.24% | 2,092,160 | 65.34K |
| 379 | GUTS | Fractyl Health, Inc. | 91.22M | -0.09% | 2,107,906 | 3.00K |
| 380 | EXOZ | eXoZymes, Inc. | 88.86M | -1.69% | 898 | -700.00 |
| 381 | GOSS | Gossamer Bio, Inc. | 88.57M | -10.14% | 9,344,786 | 48.47M |
| 382 | GANX | Gain Therapeutics, Inc. | 88.29M | -1.42% | 457,576 | - |
| 383 | ACET | Adicet Bio, Inc. | 86.64M | -7.04% | 172,332 | - |
| 384 | PYPD | PolyPid Ltd. | 86.64M | -3.20% | 40,818 | - |
| 385 | LONA | LeonaBio, Inc. | 86.61M | -1.71% | 34,974 | - |
| 386 | ATHE | Alterity Therapeutics Limited | 85.74M | -5.73% | 25,904 | 4.43M |
| 387 | FLNA | Filana Therapeutics, Inc. | 82.12M | -2.86% | 319,958 | - |
| 388 | MCRB | Seres Therapeutics, Inc. | 81.48M | -4.92% | 25,478 | 789.00K |
| 389 | NRXS | NeurAxis, Inc. | 81.45M | 4.00% | 121,882 | 3.57M |
| 390 | OKYO | OKYO Pharma Limited | 81.34M | -2.52% | 38,746 | - |
| 391 | ATYR | aTyr Pharma, Inc. | 80.75M | -3.48% | 584,458 | 190.00K |
| 392 | CSBR | Champions Oncology, Inc. | 80.54M | -4.53% | 13,201 | 57.95M |
| 393 | MAIA | MAIA Biotechnology, Inc. | 80.09M | -6.38% | 351,258 | - |
| 394 | PLRX | Pliant Therapeutics, Inc. | 79.87M | - | 752,065 | - |
| 395 | PMVP | PMV Pharmaceuticals, Inc. | 77.86M | 2.10% | 338,323 | - |
| 396 | PTHS | Pelthos Therapeutics Inc. | 77.18M | 0.22% | 17,632 | 16.80M |
| 397 | IMMP | Immutep Limited | 77.10M | -4.30% | 3,547,657 | 5.28M |
| 398 | XBIT | XBiotech Inc. | 76.83M | 0.40% | 18,221 | - |
| 399 | ESLA | Estrella Immunopharma, Inc. | 76.80M | -0.55% | 12,356 | - |
| 400 | TCRX | TScan Therapeutics, Inc. | 76.33M | -11.19% | 1,279,896 | 10.33M |
| 401 | IBO | Impact BioMedical Inc. | 75.22M | 2.59% | 93,615 | 32.00K |
| 402 | PDSB | PDS Biotechnology Corporation | 74.79M | 3.88% | 907,375 | - |
| 403 | GRCE | Grace Therapeutics, Inc. | 72.11M | 1.53% | 589,663 | - |
| 404 | FBIO | Fortress Biotech, Inc. | 71.81M | -3.88% | 320,103 | 63.26M |
| 405 | BYSI | BeyondSpring Inc. | 71.55M | -1.99% | 4,332 | 1.88M |
| 406 | SPRB | Spruce Biosciences, Inc. | 70.93M | -26.05% | 648,735 | 697.00K |
| 407 | MNOV | MediciNova, Inc. | 69.89M | -3.40% | 19,185 | 409.66K |
| 408 | ICCC | ImmuCell Corporation | 69.84M | -3.74% | 19,493 | 27.64M |
| 409 | ACRV | Acrivon Therapeutics, Inc. | 68.19M | -5.38% | 512,651 | - |
| 410 | CING | Cingulate Inc. | 68.14M | -2.82% | 734,295 | - |
| 411 | EDSA | Edesa Biotech, Inc. | 67.98M | 13.33% | 299,057 | - |
| 412 | OKUR | OnKure Therapeutics, Inc. | 66.73M | -2.20% | 59,797 | - |
| 413 | IBIO | iBio, Inc. | 66.32M | -2.54% | 559,059 | 300.00K |
| 414 | CUE | Cue Biopharma, Inc. | 65.43M | -21.14% | 13,447,517 | 27.47M |
| 415 | IMA | ImageneBio, Inc. | 64.98M | -3.17% | 30,975 | 800.00K |
| 416 | ANVS | Annovis Bio, Inc. | 64.23M | -3.12% | 894,394 | - |
| 417 | HYFT | MindWalk Holdings Corp. | 61.59M | -2.36% | 199,764 | 20.70M |
| 418 | INKT | MiNK Therapeutics, Inc. | 58.30M | -8.42% | 61,211 | - |
| 419 | OSTX | OS Therapies Incorporated | 58.01M | - | 298,623 | - |
| 420 | MGX | Metagenomi Therapeutics, Inc. | 56.43M | -1.96% | 234,098 | 25.21M |
| 421 | ENTX | Entera Bio Ltd. | 55.48M | -11.19% | 263,463 | 42.00K |
| 422 | TIL | Instil Bio, Inc. | 55.41M | -2.62% | 16,431 | - |
| 423 | KZR | Kezar Life Sciences, Inc. | 53.78M | -0.14% | 58,203 | - |
| 424 | ACTU | Actuate Therapeutics, Inc. | 53.71M | -13.55% | 310,866 | - |
| 425 | RADX | Radiopharm Theranostics Limited | 53.34M | -2.82% | 47,529 | 10.86M |
| 426 | RNTX | Rein Therapeutics Inc. | 52.43M | 2.19% | 152,689 | - |
| 427 | MREO | Mereo BioPharma Group plc | 51.72M | -3.86% | 637,229 | 500.00K |
| 428 | DWTX | Dogwood Therapeutics, Inc. | 50.94M | -4.69% | 79,579 | - |
| 429 | NTRB | Nutriband Inc. | 50.81M | -0.48% | 1,297 | 2.28M |
| 430 | ATOS | Atossa Therapeutics, Inc. | 49.69M | -6.48% | 91,372 | - |
| 431 | PSTV | Plus Therapeutics, Inc. | 48.99M | -2.19% | 349,020 | 5.21M |
| 432 | XLO | Xilio Therapeutics, Inc. | 48.63M | -0.47% | 27,029 | 43.77M |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 47.79M | -6.08% | 63,977 | - |
| 434 | ATNM | Actinium Pharmaceuticals, Inc. | 47.39M | 5.56% | 635,954 | 90.00K |
| 435 | HYPD | Hyperion DeFi, Inc. | 44.54M | -8.64% | 247,030 | 813.46K |
| 436 | HOWL | Werewolf Therapeutics, Inc. | 43.97M | -6.70% | 237,683 | 1.14M |
| 437 | RLYB | Rallybio Corporation | 43.85M | - | 22,387 | 858.00K |
| 438 | RNXT | RenovoRx, Inc. | 42.76M | -5.55% | 675,664 | 1.12M |
| 439 | LITS | Lite Strategy, Inc. | 41.09M | -5.04% | 359,274 | - |
| 440 | ATRA | Atara Biotherapeutics, Inc. | 40.81M | - | 34,336 | 120.77M |
| 441 | SNSE | Sensei Biotherapeutics, Inc. | 40.69M | -3.28% | 24,822 | - |
| 442 | ALGS | Aligos Therapeutics, Inc. | 40.59M | 0.77% | 231,449 | 2.19M |
| 443 | LIXT | Lixte Biotechnology Holdings, Inc. | 40.43M | 1.31% | 12,386 | - |
| 444 | NXTC | NextCure, Inc. | 38.35M | -7.95% | 96,244 | - |
| 445 | VERU | Veru Inc. | 38.04M | -2.47% | 23,635 | 16.89M |
| 446 | EVAX | Evaxion A/S | 37.53M | 0.22% | 28,672 | 7.53M |
| 447 | PTN | Palatin Technologies, Inc. | 37.07M | -1.00% | 14,462 | 8.96M |
| 448 | INMB | INmune Bio Inc. | 36.42M | -8.05% | 287,630 | 50.00K |
| 449 | TVGN | Tevogen Bio Holdings Inc. | 36.02M | 4.22% | 71,469 | - |
| 450 | CRVO | CervoMed Inc. | 36.02M | -2.02% | 90,015 | 4.01M |
| 451 | BOLD | Boundless Bio, Inc. | 35.40M | -1.25% | 71,388 | - |
| 452 | CELU | Celularity Inc. | 35.18M | -1.61% | 39,070 | 40.58M |
| 453 | DARE | Daré Bioscience, Inc. | 34.36M | -17.77% | 1,249,688 | 1.03M |
| 454 | SNTI | Senti Biosciences, Inc. | 34.26M | -3.51% | 297,599 | 22.00K |
| 455 | PLUR | Pluri Inc. | 33.63M | -6.80% | 7,601 | 1.34M |
| 456 | OTLK | Outlook Therapeutics, Inc. | 33.41M | -13.68% | 9,960,978 | 205.70K |
| 457 | ABVC | ABVC BioPharma, Inc. | 31.38M | -2.31% | 50,723 | 797.92K |
| 458 | CVM | CEL-SCI Corporation | 30.83M | -3.30% | 44,476 | - |
| 459 | IGC | IGC Pharma, Inc. | 30.53M | -0.13% | 1,965,552 | 1.11M |
| 460 | DYAI | Dyadic International, Inc. | 30.48M | -4.84% | 87,391 | 3.09M |
| 461 | LTRN | Lantern Pharma Inc. | 30.04M | -2.90% | 205,921 | - |
| 462 | LGVN | Longeveron Inc. | 29.87M | -1.92% | 821,802 | 1.20M |
| 463 | TVRD | Tvardi Therapeutics, Inc. | 29.55M | -2.17% | 23,183 | - |
| 464 | BCTX | BriaCell Therapeutics Corp. | 28.79M | -0.75% | 288,649 | - |
| 465 | LSTA | Lisata Therapeutics, Inc. | 28.72M | 12.37% | 190,637 | 170.00K |
| 466 | KYNB | Kyntra Bio, Inc. | 28.58M | -3.79% | 3,763 | 6.44M |
| 467 | APLM | Apollomics, Inc. | 28.17M | -3.03% | 6,181 | 6.93M |
| 468 | SKYE | Skye Bioscience, Inc. | 27.54M | 5.32% | 215,959 | - |
| 469 | AEON | AEON Biopharma, Inc. | 27.33M | 0.93% | 113,411 | - |
| 470 | NNVC | NanoViricides, Inc. | 27.21M | -1.56% | 348,861 | - |
| 471 | JSPR | Jasper Therapeutics, Inc. | 26.88M | -9.43% | 371,459 | - |
| 472 | NEUP | Neuphoria Therapeutics Inc. | 26.43M | -2.53% | 29,539 | 14.99M |
| 473 | MRKR | Marker Therapeutics, Inc. | 26.01M | -6.59% | 59,235 | 3.55M |
| 474 | TPST | Tempest Therapeutics, Inc. | 25.39M | -8.76% | 233,163 | - |
| 475 | SER | Serina Therapeutics, Inc. | 25.12M | -2.86% | 94,737 | 130.00K |
| 476 | NRSN | NeuroSense Therapeutics Ltd. | 24.39M | -2.82% | 94,931 | - |
| 477 | BRNS | Barinthus Biotherapeutics plc | 24.10M | - | 20,131 | 14.97M |
| 478 | VTGN | Vistagen Therapeutics, Inc. | 23.99M | -0.54% | 368,215 | 789.00K |
| 479 | XCUR | Exicure, Inc. | 23.97M | -0.21% | 12,817 | 500.00K |
| 480 | CRIS | Curis, Inc. | 23.96M | -2.87% | 452,581 | 9.44M |
| 481 | LEXX | Lexaria Bioscience Corp. | 23.53M | -4.50% | 328,953 | 368.00K |
| 482 | PLRZ | Polyrizon Ltd. | 22.23M | 7.13% | 244,986 | - |
| 483 | QNCX | Quince Therapeutics, Inc. | 21.84M | 5.51% | 1,711,000 | - |
| 484 | ALLR | Allarity Therapeutics, Inc. | 21.83M | 10.40% | 447,634 | 320.00K |
| 485 | PBM | Psyence Biomedical Ltd. | 21.76M | -16.02% | 4,182,389 | - |
| 486 | VYNE | VYNE Therapeutics Inc. | 21.32M | 1.06% | 148,474 | 570.00K |
| 487 | QNTM | Quantum BioPharma Ltd. | 20.07M | 10.26% | 1,191,211 | - |
| 488 | PASG | Passage Bio, Inc. | 19.82M | -1.12% | 399,194 | - |
| 489 | COCP | Cocrystal Pharma, Inc. | 19.71M | -5.30% | 150,658 | - |
| 490 | OSRH | OSR Holdings, Inc. | 19.54M | -1.68% | 468,287 | 2.91M |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 18.91M | -3.35% | 325,108 | 3.94M |
| 492 | KTTA | Pasithea Therapeutics Corp. | 17.21M | -3.81% | 465,431 | - |
| 493 | LPCN | Lipocine Inc. | 17.15M | 2.17% | 277,878 | 1.98M |
| 494 | ICU | SeaStar Medical Holding Corporation | 17.13M | -7.34% | 73,393 | 1.23M |
| 495 | JUNS | Jupiter Neurosciences, Inc. | 16.88M | 1.13% | 51,429 | 21.80K |
| 496 | GNTA | Genenta Science S.p.A. | 16.28M | -1.54% | 48,119 | - |
| 497 | CDT | CDT Equity Inc. | 16.08M | -1.34% | 27,689 | - |
| 498 | HIND | Vyome Holdings, Inc. | 15.86M | -3.83% | 25,385 | 319.71K |
| 499 | TOVX | Theriva Biologics, Inc. | 15.54M | -17.39% | 58,294,439 | - |
| 500 | NCEL | NewcelX Ltd. | 15.41M | 19.43% | 204,815 | - |